abs360.txt	background		prostate	cancer	incidence	rates	vary	25-fold	worldwide	differencesin	psa	screening	are	largely	but	not	entirely	responsible	we	examinedgeographic	differences	in	prevalence	of	histologic	inflammation	andsubsequent	risk	methods	seven	thousand	nonhispanic	white	menwere	enrolled	the	reduction	by	dutasteride	events	(reduce)trial	from	europe	(n	=	4	644)	north	america	1	746)	south	=466)	and	australia/new	zealand	144)	baselinenegative	biopsies	was	classified	as	chronic	(lymphocytes/macrophages)	oracute	(neutrophils)	multivariable	logistic	regression	used	to	examineassociations	between	region	andprostate	at	2-year	biopsy	results	prostateinflammation	varied	across	with	broadly	similar	patterns	for	acute	andchronic	relative	washigher	[odds	ratio	(or)	77	95%	confidence	interval	(ci)	51-2	08]	(or	2	07	ci	40-3	06)	men	fromthese	regions	had	lower	than	europeans	amongnorth	americans	higher	canada	versus	theunited	states	40	07-1	83)	did	notdiffer	these	among	inflammationwas	northern	eastern	0	79	65-0	97	or	62	95%ci	45-0	87	respectively)	western	hadhigher	conclusions	histologicprostate	geographic	tracked	inversely	cancerrisk	impact	characterization	premalignant	biology	therelationship	subsequent	could	inform	cancerprevention	efforts	epidemiol	biomarkers	prev	27(7)	783-9	Â©2018	aacr
